Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 02, 2025 08:05 ET | Source: Sangamo Therapeutics, Inc.

Sangamo Therapeutics Receives U.S. FDA Fast Track Designation for ST-503 for the Treatment of Small Fiber Neuropathy

Sangamo Therapeutics today announced that the FDA has granted Fast Track Designation to ST-503 in chronic neuropathic pain
November 06, 2025 08:01 ET | Source: Sangamo Therapeutics, Inc.

Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2025 Financial Results

SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND THIRD QUARTER 2025 FINANCIAL RESULTS